An announcement from CSPC PHARMA (HKEX: 01093) discloses that on June 26, 2026, the trustee of the company acted in accordance with the 2026 Share Award Scheme.
The trustee purchased a total of 4.4 million shares of the company on the open market. These shares are now held in trust for the benefit of selected participants in the incentive plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments